Altium Capital Management LP Sutro Biopharma, Inc. Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.03 - $23.82 $4.09 Million - $5.4 Million	-226,719 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$20.29 - $27.54 $1.01 Million - $1.38 Million	-50,000 Reduced 18.07%	226,719 $5.16 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $2.81 Million - $6.64 Million	276,719 New	276,719 $6.01 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.